Stay updated on Pembrolizumab Combo in Advanced Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in Advanced Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab Combo in Advanced Melanoma Clinical Trial page
- Check4 days agoChange DetectedThe Record History page now shows Revision: v3.7.0, replacing the previous v3.6.6. This indicates a site update to the page's UI/backend.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedRevision: v3.6.6 replaces v3.6.5 on the page's history display. This indicates a new build of the history page was deployed.SummaryDifference0.0%

- Check25 days agoNo Change Detected
- Check39 days agoChange DetectedThe page history shows a revision bump from v3.6.4 to v3.6.5, indicating a minor update to the ClinicalTrials.gov interface. No study details or visible content appear to be modified.SummaryDifference0.0%

- Check53 days agoChange DetectedA new history entry labeled Revision: v3.6.4 appears in the record history, while the previous Revision: v3.6.3 entry is removed, reflecting an update to the page's revision log rather than changes to study data.SummaryDifference0.0%

- Check82 days agoChange DetectedThe revision stamp on the page has been updated from v3.6.0 to v3.6.3, indicating a newer release of the ClinicalTrials.gov interface used for the history view.SummaryDifference0.0%

- Check96 days agoChange DetectedThe recruitment status has changed to 'No longer looking for participants,' indicating enrollment is closed. The record revision version was updated from v3.5.5 to v3.6.0.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab Combo in Advanced Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Advanced Melanoma Clinical Trial page.